glp 1 for cardiovascular health Semaglutide Shows Secondary Prevention Benefits in Patients Without Diabetes How GLP-1 Medications Reduce Heart

J Am Board Fam Med 26:203210 Meier JJ (2012) GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

Scenario A- GLP-1s become a standard treatment, like statins for cholesterol

Here we show that oral administration of the non-calorie sweetener, rare sugar d-allulose (d-psicose), induces GLP-1 release, activates vagal afferent signaling, reduces food intake and promotes glucose tolerance in healthy and obese-diabetic animal models

James Wantuck, MD, associate chief medical officer, Accolade & PlushCare As associate chief medical officer at Accolade and co-founder of PlushCare, Dr

doi: 10.1111/j.2040-1124.2010.00022.x

But the bigger shift is everything wrapped around the medication